$134 Million is the total value of Opus Point Partners Management, LLC's 57 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IBB | New | ISHARES TRnasdq biotec etf | $6,067,000 | – | 20,000 | +100.0% | 3.35% | – |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $3,247,000 | – | 46,000 | +100.0% | 1.79% | – |
| BMY | New | BRISTOL MYERS SQUIBB CO | $2,131,000 | – | 36,000 | +100.0% | 1.18% | – |
| MRK | New | MERCK & CO INC NEW | $2,025,000 | – | 41,000 | +100.0% | 1.12% | – |
| ZGNX | New | ZOGENIX INC | $887,000 | – | 65,700 | +100.0% | 0.49% | – |
| NVAX | New | NOVAVAX INCcall | $707,000 | – | 100,000 | +100.0% | 0.39% | – |
| NVAX | New | NOVAVAX INCput | $707,000 | – | 100,000 | +100.0% | 0.39% | – |
| RPRX | New | REPROS THERAPEUTICS INCcall | $494,000 | – | 98,000 | +100.0% | 0.27% | – |
| AXGT | New | AXOVANT SCIENCES LTD | $397,000 | – | 30,722 | +100.0% | 0.22% | – |
| OPHT | New | OPHTHOTECH CORP | $290,000 | – | 7,150 | +100.0% | 0.16% | – |
| LABU | New | DIREXION SHS ETF TR | $241,000 | – | 14,850 | +100.0% | 0.13% | – |
| KPTI | New | KARYOPHARM THERAPEUTICS INC | $155,000 | – | 14,750 | +100.0% | 0.09% | – |
| FLDM | New | FLUIDIGM CORP DEL | $122,000 | – | 15,000 | +100.0% | 0.07% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-11-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| METTLER-TOLEDO INTL CMN | 20 | Q3 2019 | 4.7% |
| ALNYLAM PHARMACEUTICALS, INC. CMN | 20 | Q3 2019 | 5.0% |
| VERTEX PHARMACEUTICALS INC CMN | 20 | Q3 2019 | 4.0% |
| ILLUMINA, INC. CMN | 20 | Q3 2019 | 4.4% |
| SEATTLE GENETICS, INC. CMN | 20 | Q3 2019 | 4.0% |
| ALEXION PHARMACEUTICALS INC CMN | 20 | Q3 2019 | 4.3% |
| INCYTE CORPORATION CMN | 20 | Q3 2019 | 4.4% |
| NEKTAR THERAPEUTICS CMN | 20 | Q3 2019 | 4.9% |
| REGENERON PHARMACEUTICALS | 20 | Q3 2019 | 3.8% |
| CELGENE CORPORATION CMN | 20 | Q3 2019 | 3.8% |
View Opus Point Partners Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
| 13F-HR | 2019-05-15 |
| 13F-HR | 2019-02-14 |
| 13F-HR | 2018-11-14 |
| 13F-HR | 2018-08-14 |
| 13F-HR | 2018-05-15 |
| 13F-HR | 2018-02-14 |
| 13F-HR/A | 2017-11-17 |
| 13F-HR | 2017-11-14 |
View Opus Point Partners Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.